Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Immunotherapy × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Small Cell Lung Carcinoma 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Neoplasm, Residual 1 Muscle-invasive Bladder Cancer 1 Melanoma 1 Liver Neoplasms 1 Liver Diseases 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

pembrolizumab 15 enfortumab vedotin 10 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡